BioWorld

Biopharma’s trusted news source

[BioWorld @BioWorld]

'Landmark' @moderna_tx, @Merck mRNA melanoma data headline August https://t.co/YQNompbGvg #biopharma #clinics

[BioWorld @BioWorld]

Edwards’ breakthrough heart disease valve for kids wins @US_FDA approval https://t.co/ATUcHKIybR #medtech #Autus #heartdisease #pediatric

[BioWorld @BioWorld]

Fibrous optics improving in CD as Agomab mulls phase IIb https://t.co/ogrPRkXdG2 #biopharma #alk5 #Crohns

[BioWorld @BioWorld]

.@Novartis taps Abogen’s #RNA platform in potential $7.8B #deal (free w/one-time registration) https://t.co/8RX76bvcNo #biopharma

[BioWorld @BioWorld]

Australia bets on clinical trials as its next growth engine https://t.co/5PDYjCtbBg #biopharma #lifesciences #clinicaltrials #Australia #drugdevelopment

[BioWorld @BioWorld]

#EASD2026: New weight loss targets aim to preserve or restore muscle mass https://t.co/435QIMlpig #biopharma #obesity #weightloss #musclemass @EASDnews

[BioWorld @BioWorld]

Qbiotics builds on 78% response with AU$40M raise https://t.co/RcivqEvj2i #biopharma #oncology #CancerResearch #ClinicalTrials #AustraliaBiotech

[BioWorld @BioWorld]

Medicus makes melanoma ADC ‘strategic priority’ post-@Pfizer deal https://t.co/bjP9KF760N #biopharma #melanoma #ADC #deal

[BioWorld @BioWorld]

Fewer, bigger #deals drive med-tech M&A rebound in 2026 https://t.co/XK1vyIWBVp #medtech @teleflex

[BioWorld @BioWorld]

New @CMSGov model saving $440M, exempts rare disease drugs https://t.co/qfQrXsIy9m #biopharma #raredisease

[BioWorld @BioWorld]

.@foghorntx cuts staff 40% as @EliLillyandCo terminates SMARCA2 deal https://t.co/7nZUCPW6io #biopharma #deals #restructuring

[BioWorld @BioWorld]

#LSIEurope26: Stryker CEO says #AI will become an ‘intelligent partner’ in healthcare https://t.co/Z3RgK848MZ #medtech #roboticsurgery #MakoSmartrobotics #Blueprint

[BioWorld @BioWorld]

.@Sanofi to ‘ignite’ R&D in $8B #deal with longstanding partner @Regeneron (free w/one-time registration) https://t.co/mE3d4jzpNz #biopharma #Dupixent #inflammatory #immune #antibodies #atopicdermatitis #psoriasis #COPD #multiplesclerosis

[BioWorld @BioWorld]

From ‘holy grail’ hope to insolvency: @ParadigmBio's rapid fall https://t.co/LgTTzt7KHk #biopharma #osteoarthritis #ClinicalTrials #Australia

[BioWorld @BioWorld]

.@Atarabio, @PierreFabre take third shot at FDA approval of #Ebvallo https://t.co/p52RYlx4uI #biopharma #raredisease #celltherapy #hematology #approval

[BioWorld @BioWorld]

China exerting dominance in early stage clinical trials https://t.co/dHdSFu8ltX #biopharma #China #Australia #ClinicalTrials @incub8coalition @housescience @MassBio

[BioWorld @BioWorld]

#LSIEurope26: Xeltis on its way to being attractive to strategics https://t.co/NqtDuI0QlP #medtech #kidneydisease #hemodialysis #Axess

[BioWorld @BioWorld]

#AACRpan26: Developing better pancreatic clinical trials https://t.co/vcOpdugC5b #biopharma #pancreaticcancer @AACR

[BioWorld @BioWorld]

Companies pool data to train #AI to predict #antibody developability https://t.co/sE40wWuhJp #biopharma #medtech

[BioWorld @BioWorld]

Triple agonist, amylin combo approaches take stage at #EASD2026 (free w/one-time registration) https://t.co/MKRa9osbOC #biopharma #diabetes #obesity #clinical @EliLillyandCo @EASDnews